Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Fam Cancer. 2012 Mar;11(1):97–106. doi: 10.1007/s10689-011-9486-2

Table 5.

Genetic Testing Decisions Among Participants

IGC GGC
Tested 78% (25) 47% (8)
Type of testing among those tested Full BRCA1/2 Analysis 68% (17) 63% (5)
Familial mutation testing 32% (8) 37% (3)
Reasons for declining testing Lack of insurance coverage/cost 62% (5) 44% (4)
Not interested/did not feel it would change management 0% 22% (2)
Further evaluation recommended before testing/determined not to be appropriate candidate 13% (1) 11% (1)
No reason given 13% (1) 22% (2)